Dublin, April 12, 2023 (GLOBE NEWSWIRE) -- The "Lymphoma Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Lymphoma Therapeutics estimated at US$14.9 Billion in the year 2022, is projected to reach a revised size of US$25.2 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2022-2030.
Non-Hodgkin Lymphoma (NHL), one of the segments analyzed in the report, is projected to record 6.5% CAGR and reach US$20.5 Billion by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Hodgkin Lymphoma (HL) segment is readjusted to a revised 7.9% CAGR for the next 8-year period.
The U.S. Market is Estimated at $4.1 Billion, While China is Forecast to Grow at 10.9% CAGR
The Lymphoma Therapeutics market in the U.S. is estimated at US$4.1 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.7 Billion by the year 2030 trailing a CAGR of 10.9% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.
Select Competitors (Total 93 Featured) -
- Amgen, Inc.
- Astellas Pharma, Inc.
- AstraZeneca PLC
- Bristol-Myers Squibb Company
- Celgene Corporation
- Chugai Pharmaceutical Co., Ltd.
- Eisai Co., Ltd.
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- Forma Therapeutics, Inc.
- GlaxoSmithKline PLC
- Immunomedics, Inc.
- Johnson & Johnson
- Merck & Co., Inc.
- Pfizer, Inc.
- Seattle Genetics, Inc.
- Spectrum Pharmaceuticals
- Transgene SA
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 406 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $14.9 Billion |
| Forecasted Market Value (USD) by 2030 | $25.2 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Lymphoma Therapeutics - Global Key Competitors Percentage Market Share in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
- Cancer Evolves Into the Global Epidemic
- Global New Cancer Incidence (In Million) for the Year 2020
- COVID-19 Extends a Major Setback to the World's Battle Against Cancer
- Lymphoma: Disease Causes, Risks, Types, Symptoms, Diagnosis & Survival
- New Cases of Leukemia, Lymphoma and Myeloma in the U.S. for the Year 2020
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Targeted Therapies Grow in Popularity for Treating Lymphoma
- CT Imaging: The Gold Standard & Workhorse of Lymphoma Diagnoses & Monitoring
- 'Liquid Biopsy' Rises in Prominence Among All Other Types of Lymph Node Biopsies
- Advancements in the Field of Genomics Brings Hope for the Development of More Potent Cancer
- What Are the Approved Drugs for Lymphoma?
- Artificial Intelligence Helps Speed Up & Automate Lymphoma Diagnosis
- Global Market for AI in Healthcare (US$ Billion) for Years 2020, 2022 & 2024
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/4g3rip
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
